Pulmonary actinomycosis complicating infliximab therapy for Crohn's disease

被引：23

作者：

Cohen, R. D. ^{[1
]}

Bowie, W. R.

Enns, R.

Flint, J.

Fitzgerald, J. M.

机构：

[1] Univ British Columbia, Dept Med, Vancouver, BC, Canada

[2] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada

来源：

THORAX | 2007年 / 62卷 / 11期

关键词：

D O I：

10.1136/thx.2006.075150

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

The use of anti-tumour necrosis factor (TNF) agents has expanded significantly over the past few years, particularly for rheumatologtcal diseases and Crohn's disease. A number of associated opportunistic infections have been observed as a result of suppression of T cell-mediated immunity, the most frequent being tuberculosis. We report the first case of pulmonary actinomycosis in a patient receiving regular infusions of infliximab, an anti-TNF agent, for Crohn's disease.

引用

页码：1013 / 1014

页数：2

共 13 条

[1] ENDOBRONCHIAL ACTINOMYCOSIS SIMULATING BRONCHOGENIC-CARCINOMA - DIAGNOSIS BY BRONCHIAL BIOPSY [J].

ARIEL, I ;

BREUER, R ;

KAMAL, NS ;

BENDOV, I ;

MOGLE, P ;

ROSENMANN, E .

CHEST, 1991, 99 (02) :493-495

[2] Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis [J].

Baert, FJ ;

D'Haens, GR ;

Peeters, M ;

Hiele, MI ;

Schaible, TF ;

Shealy, D ;

Geboes, K ;

Rutgeerts, PJ .

GASTROENTEROLOGY, 1999, 116 (01) :22-28

[3] Actinomyces odontolyticus thoracopulmonary infections - Two cases in lung and heart-lung transplant recipients and a review of the literature [J].

Bassiri, AG ;

Girgis, RE ;

Theodore, J .

CHEST, 1996, 109 (04) :1109-1111

[4]

Bell SJ, 2000, ALIMENT PHARM THER, V14, P501

[5] Complications of biological therapy for inflammatory bowel diseases [J].

Blonski, W ;

Lichtenstein, GR .

CURRENT OPINION IN GASTROENTEROLOGY, 2006, 22 (01) :30-43

[6] PULMONARY ACTINOMYCOSIS - A CAUSE OF ENDOBRONCHIAL DISEASE IN A PATIENT WITH AIDS [J].

CENDAN, I ;

KLAPHOLZ, A ;

TALAVERA, W .

CHEST, 1993, 103 (06) :1886-1887

[7] Lung, pleural and colon actinomycosis in an immunocompromised patient: A rare form of presentation [J].

Charalabopoulos, K ;

Charalabopoulos, AK ;

Papalimneou, V ;

Ioachim, E ;

Constantopoulos, SH .

CHEMOTHERAPY, 2003, 49 (04) :209-211

[8] Infections associated with tumor necrosis factor-α antagonists [J].

Crum, NF ;

Lederman, ER ;

Wallace, MR .

MEDICINE, 2005, 84 (05) :291-302

[9]

FISHER MS, 1980, J CAN ASSOC RADIOL, V31, P149

[10] Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial [J].

Reich, K ;

Nestle, FO ;

Papp, K ;

Ortonne, JP ;

Evans, R ;

Guzzo, C ;

Li, S ;

Dooley, LT ;

Griffiths, CEM .

LANCET, 2005, 366 (9494) :1367-1374

← 1 2 →